Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs

Edoardo Carretto, Flavia Brovarone, Giuseppe Russello, Paola Nardini, Maisra M. El-Bouseary, Ali F. Aboklaish, Timothy R. Walsh, Jonathan M. Tyrrell

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The global spread of multidrug-resistant Gram-negative bacteria has led to the return of colistin for treating severe infections. Recently, different plasmid-mediated genes conferring resistance to this drug were described and reported worldwide. International committees (EUCAST/CLSI) reevaluated inconsistencies surrounding colistin antimicrobial susceptibility testing (AST), concluding that broth microdilution (BMD) should serve as the reference method for AST. The development of an accurate, reproducible commercial test based on BMD is therefore highly desirable. SensiTest Colistin (STC), a BMD-based compact 4-test panel containing the lyophilized antibiotic in 7 2-fold dilutions (0.25 to 16 g/ml) was here compared with the EUCAST-CLSI standard reference method (BMD) and, for some isolates, with the automated Phoenix 100 system (PHX). A total of 353 bacterial strains were evaluated by two different laboratories; 137 isolates were resistant to colistin (19 were intrinsically resistant, 83 harbored the mcr-1 gene). Essential agreement (EA) between STC and BMD was obtained for 339 out of the 353 strains tested (96.0%). Overall categorical agreement was obtained for 349 out of the 353 strains analyzed (98.9%). Two major errors (MEs; 0.93%) and two very major errors (VMEs; 1.46%) were documented. STC appeared to be a simple but highly reliable test with good reproducibility even with panels stored at room temperature or at 35°C. Moreover, STC showed a good performance with strains carrying the mcr-1 gene, with a 98.8% EA. As the secondary endpoint of our study, VMEs for PHX were documented for 6 isolates (10%).

Original languageEnglish
Article numbere01523
JournalJournal of Clinical Microbiology
Volume56
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

Colistin
Genes
Gram-Negative Bacteria
Drug Resistance
Plasmids
Anti-Bacterial Agents
Temperature
Infection

Keywords

  • Antimicrobial susceptibility testing
  • Becton Dickinson
  • Colistin
  • Liofilchem
  • MIC
  • multidrug resistance
  • Phoenix 100 system
  • SensiTest Colistin

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Carretto, E., Brovarone, F., Russello, G., Nardini, P., El-Bouseary, M. M., Aboklaish, A. F., ... Tyrrell, J. M. (2018). Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs. Journal of Clinical Microbiology, 56(4), [e01523]. https://doi.org/10.1128/JCM.01523-17

Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs. / Carretto, Edoardo; Brovarone, Flavia; Russello, Giuseppe; Nardini, Paola; El-Bouseary, Maisra M.; Aboklaish, Ali F.; Walsh, Timothy R.; Tyrrell, Jonathan M.

In: Journal of Clinical Microbiology, Vol. 56, No. 4, e01523, 01.04.2018.

Research output: Contribution to journalArticle

Carretto, E, Brovarone, F, Russello, G, Nardini, P, El-Bouseary, MM, Aboklaish, AF, Walsh, TR & Tyrrell, JM 2018, 'Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs', Journal of Clinical Microbiology, vol. 56, no. 4, e01523. https://doi.org/10.1128/JCM.01523-17
Carretto, Edoardo ; Brovarone, Flavia ; Russello, Giuseppe ; Nardini, Paola ; El-Bouseary, Maisra M. ; Aboklaish, Ali F. ; Walsh, Timothy R. ; Tyrrell, Jonathan M. / Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs. In: Journal of Clinical Microbiology. 2018 ; Vol. 56, No. 4.
@article{9a997673ce8a4c8f8d5d326277d508f4,
title = "Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs",
abstract = "The global spread of multidrug-resistant Gram-negative bacteria has led to the return of colistin for treating severe infections. Recently, different plasmid-mediated genes conferring resistance to this drug were described and reported worldwide. International committees (EUCAST/CLSI) reevaluated inconsistencies surrounding colistin antimicrobial susceptibility testing (AST), concluding that broth microdilution (BMD) should serve as the reference method for AST. The development of an accurate, reproducible commercial test based on BMD is therefore highly desirable. SensiTest Colistin (STC), a BMD-based compact 4-test panel containing the lyophilized antibiotic in 7 2-fold dilutions (0.25 to 16 g/ml) was here compared with the EUCAST-CLSI standard reference method (BMD) and, for some isolates, with the automated Phoenix 100 system (PHX). A total of 353 bacterial strains were evaluated by two different laboratories; 137 isolates were resistant to colistin (19 were intrinsically resistant, 83 harbored the mcr-1 gene). Essential agreement (EA) between STC and BMD was obtained for 339 out of the 353 strains tested (96.0{\%}). Overall categorical agreement was obtained for 349 out of the 353 strains analyzed (98.9{\%}). Two major errors (MEs; 0.93{\%}) and two very major errors (VMEs; 1.46{\%}) were documented. STC appeared to be a simple but highly reliable test with good reproducibility even with panels stored at room temperature or at 35°C. Moreover, STC showed a good performance with strains carrying the mcr-1 gene, with a 98.8{\%} EA. As the secondary endpoint of our study, VMEs for PHX were documented for 6 isolates (10{\%}).",
keywords = "Antimicrobial susceptibility testing, Becton Dickinson, Colistin, Liofilchem, MIC, multidrug resistance, Phoenix 100 system, SensiTest Colistin",
author = "Edoardo Carretto and Flavia Brovarone and Giuseppe Russello and Paola Nardini and El-Bouseary, {Maisra M.} and Aboklaish, {Ali F.} and Walsh, {Timothy R.} and Tyrrell, {Jonathan M.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1128/JCM.01523-17",
language = "English",
volume = "56",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Clinical validation of SensiTest colistin, a broth microdilution-based method to evaluate colistin MICs

AU - Carretto, Edoardo

AU - Brovarone, Flavia

AU - Russello, Giuseppe

AU - Nardini, Paola

AU - El-Bouseary, Maisra M.

AU - Aboklaish, Ali F.

AU - Walsh, Timothy R.

AU - Tyrrell, Jonathan M.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - The global spread of multidrug-resistant Gram-negative bacteria has led to the return of colistin for treating severe infections. Recently, different plasmid-mediated genes conferring resistance to this drug were described and reported worldwide. International committees (EUCAST/CLSI) reevaluated inconsistencies surrounding colistin antimicrobial susceptibility testing (AST), concluding that broth microdilution (BMD) should serve as the reference method for AST. The development of an accurate, reproducible commercial test based on BMD is therefore highly desirable. SensiTest Colistin (STC), a BMD-based compact 4-test panel containing the lyophilized antibiotic in 7 2-fold dilutions (0.25 to 16 g/ml) was here compared with the EUCAST-CLSI standard reference method (BMD) and, for some isolates, with the automated Phoenix 100 system (PHX). A total of 353 bacterial strains were evaluated by two different laboratories; 137 isolates were resistant to colistin (19 were intrinsically resistant, 83 harbored the mcr-1 gene). Essential agreement (EA) between STC and BMD was obtained for 339 out of the 353 strains tested (96.0%). Overall categorical agreement was obtained for 349 out of the 353 strains analyzed (98.9%). Two major errors (MEs; 0.93%) and two very major errors (VMEs; 1.46%) were documented. STC appeared to be a simple but highly reliable test with good reproducibility even with panels stored at room temperature or at 35°C. Moreover, STC showed a good performance with strains carrying the mcr-1 gene, with a 98.8% EA. As the secondary endpoint of our study, VMEs for PHX were documented for 6 isolates (10%).

AB - The global spread of multidrug-resistant Gram-negative bacteria has led to the return of colistin for treating severe infections. Recently, different plasmid-mediated genes conferring resistance to this drug were described and reported worldwide. International committees (EUCAST/CLSI) reevaluated inconsistencies surrounding colistin antimicrobial susceptibility testing (AST), concluding that broth microdilution (BMD) should serve as the reference method for AST. The development of an accurate, reproducible commercial test based on BMD is therefore highly desirable. SensiTest Colistin (STC), a BMD-based compact 4-test panel containing the lyophilized antibiotic in 7 2-fold dilutions (0.25 to 16 g/ml) was here compared with the EUCAST-CLSI standard reference method (BMD) and, for some isolates, with the automated Phoenix 100 system (PHX). A total of 353 bacterial strains were evaluated by two different laboratories; 137 isolates were resistant to colistin (19 were intrinsically resistant, 83 harbored the mcr-1 gene). Essential agreement (EA) between STC and BMD was obtained for 339 out of the 353 strains tested (96.0%). Overall categorical agreement was obtained for 349 out of the 353 strains analyzed (98.9%). Two major errors (MEs; 0.93%) and two very major errors (VMEs; 1.46%) were documented. STC appeared to be a simple but highly reliable test with good reproducibility even with panels stored at room temperature or at 35°C. Moreover, STC showed a good performance with strains carrying the mcr-1 gene, with a 98.8% EA. As the secondary endpoint of our study, VMEs for PHX were documented for 6 isolates (10%).

KW - Antimicrobial susceptibility testing

KW - Becton Dickinson

KW - Colistin

KW - Liofilchem

KW - MIC

KW - multidrug resistance

KW - Phoenix 100 system

KW - SensiTest Colistin

UR - http://www.scopus.com/inward/record.url?scp=85042457529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042457529&partnerID=8YFLogxK

U2 - 10.1128/JCM.01523-17

DO - 10.1128/JCM.01523-17

M3 - Article

AN - SCOPUS:85042457529

VL - 56

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

M1 - e01523

ER -